Chronic obstructive pulmonary disease (COPD) is one of the world’s most common chronic diseases, and consists of chronic bronchitis that involves chronic inflammation of the bronchi, or emphysema that involves destruction of lung alveoli. In COPD patients, the airways become narrowed, and the airflow is irreversibly obstructed. This leads to a limitation of the flow of air to and from the lungs, causing shortness of breath (dyspnea), as well as abnormal inflammatory response in the lung. Nowadays, COPD is often under-diagnosed, as spirometry was not performed until patient has significant symptoms of dyspnea, cough and sputum production. At that stage, the COPD patients may have reached an advanced stage with considerable loss of lung function. Thus, biomarkers are of great interest for research and clinical purposes in COPD, especially for early diagnosis of COPD. In this study, the relationship between plasma levels of different biomarkers, including monocyte chemoattractant protein-1 (MCP)-1 (a primary chemoattractant biomarker), matrix metalloproteinase nine (MMP)-9, vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) (injury and repair biomarkers), and growth differentiation factor 15 (GDF)-15 (a novel biomarker), in 29 healthy ever-smokers and 116 COPD patients was investigated using commercially available enzyme-linked immunosorbent assay (ELISA) kits. We also investigated the correlations between these biomarkers and lung function. There were significant increases in plasma MCP-1, MMP-9, HGF and GDF-15 in COPD patients compared to healthy smokers. Among ever-smokers with or without COPD, plasma MCP-1, MMP-9 and HGF levels were inversely correlated with force expiratory volume in one second![FEV1 (% predicted)] after adjustment for age, smoking status and packyears smoked. Correlation was also found between plasma MCP-1 and HGF, plasma MMP-9 and HGF or GDF-15, plasma HGF and GDF-15 after adjustment for age, smoking status and pack-years smoked. Further multiple linear regression analyses demonstrated that plasma MMP-9 level increased with the COPD GOLD stages. In conclusion, our findings suggest that MMP-9 might be as an important biomarker for COPD initiation and progression. As this study provides only evidence of association rather than of causation, prospective studies are required to assess biological significance of these associations between the plasma biomarkers. / published_or_final_version / Medicine / Master / Master of Medical Sciences

BACKGROUND: In children, sleep-related airway obstruction by large tonsils and adenoids can cause obstructive sleep apnea (OSA). OSA may lead to poor growth, developmental delay, behaviour or learning problems. Recent evidence also suggests that children with OSA may develop cardiovascular complications, the mechanisms perhaps involving hypoxemia, the autonomic nervous system, apneas, and arousals. Surgical removal of tonsils and adenoids (adenotonsillectomy (T&A)) usually cures pediatric OSA. To diagnose OSA at all levels of severity, polysomnography is currently the best approach. The McGill Oximetry Score (MOS) is a validated measure based on nocturnal pulse oximetry. An abnormal MOS has a 97% positive predictive value at detecting moderate-severe OSA. Because the MOS was devised by measuring frequency of desaturations (<90%) and numbers of clusters of desaturations, it is not accurate at detecting OSA in children who do not have such drops in oxygen saturation. Accordingly, other measures applicable to a wider spectrum of children should be assessed. These measures should be simpler, less cumbersome, cheaper, and more accessible than polysomnography. / OBJECTIVES: To study alternative approaches that may be used to identify moderate-severe OSA in children, two studies were conducted. We examined one subjective measure - the OSA-18 parent questionnaire - and two objective measures - pulse rate and pulse rate variability. For the OSA-18 study, the goal was to determine whether it would accurately detect children with moderate-severe OSA as indicated by an abnormal MOS. For the pulse rate and pulse rate variability study, the goal was to determine if either or both would decrease after treatment with T&A for children with moderate-severe OSA. / METHODS: For the OSA-18 study, we used a cross-sectional design that included children 1-18 years old referred to a pediatric sleep laboratory for evaluation of suspected OSA. Alongside data from the OSA-18, we analyzed demographic and medical data (from a parent questionnaire) and information regarding adenotonsillar hypertrophy. We estimated sensitivity, specificity, positive and negative predictive values as well as receiver operating curves of the OSA-18 in detecting an abnormal MOS. We also conducted univariate and multivariate logistic regression analyses, using the MOS as the dependent variable and the OSA-18 score and others (age, gender, comorbidities, race) as independent variables. For the second study, we used a retrospective before-after design to compare pulse rate and pulse rate variability as measured by nocturnal pulse oximetry pre- and post-T&A of otherwise healthy children 1-18 years old with moderate-to-severe OSA. / RESULTS: For the OSA-18 study, we studied 334 children (58% male, mean age 4.6 +/- 2.2 years). The OSA-18 had a sensitivity of 40% and a negative predictive value of 73% for detecting an abnormal MOS. In addition, the area under the receiver operating curve was 0.611. While controlling for other independent variables in the logistic regression model, for each unit increase in the OSA-18 Score, the odds of having an abnormal MOS were increased by 2%. However, for each increase in age of 1 year, the odds of having an abnormal MOS were decreased by 17%. In the pulse rate and pulse rate variability study, 25 subjects (88% male; mean age 4.3 +/- 3.6 years) were enrolled. Following T&A, pulse rate and pulse rate variability decreased in 21 of 25 and 23 of 25 children, respectively. Mean pulse rate dropped from 99.7+/-11.2 to 90.1+/-10.7 bpm, p<0.001; age-standardized pulse rate (z-score) from 0.8 (0.4, 1.5) to 0.4 (0, 0.9), p=0.04). Pulse rate variability, as measured by the standard deviation of the pulse rate decreased from 10.3 +/- 2.1 to 8.2 +/- 1.6 bpm, p<0.001. As well, OSA symptomatology, parental concern about breathing during sleep and the MOS all improved. / CONCLUSIONS: Based on the first study we conclude that among children referred to a sleep laboratory, the OSA-18 does not accurately detect which children will have an abnormal MOS. The OSA-18 should not be used in place of objective testing to identify moderate-severe OSA in children. However, from the second study we conclude that measures of the autonomic nervous system such as pulse rate and pulse rate variability, as measured by pulse oximetry, decreased following surgical treatment of moderate-severe OSA. The results of this study potentially serve as important data for further work that would determine the accuracy of pulse rate and pulse rate variability measures and their diagnostic usefulness for OSA at all levels of severity.

No description available.

Obstructive sleep apnea (OSA) occurs commonly in the U.S. population and is seen in both obese as well as non-obese individuals. OSA is a disease characterized by periodic upper airway collapse during sleep, which then results in either apnea, hypopnea, or both. The disorder leads to a variety of medical complications. Neuropsychiatric complications include daytime somnolence, cognitive dysfunction, and depression. Increased incidence of motor vehicle accidents has been documented in these patients and probably reflects disordered reflex mechanisms or excessive somnolence. More importantly, vascular disorders such as hypertension, stroke, congestive cardiac failure, arrhythmias, and atherosclerosis occur frequently in these patients. The lungs may be affected by pulmonary hypertension and worsening of asthma. Recent data from several laboratories demonstrate that obstructive sleep apnea is characterized by an inflammatory response. Cytokines are elaborated during the hypoxemic episodes leading to inflammatory responses as marked clinically by elevated C-reactive protein (CRP). As elevated CRP levels are considered markers of the acute phase response and characterize progression of vascular injury in coronary artery disease, it is likely that obstructive sleep apnea could lead to worsening of vasculopathy. Moreover, as inflammatory mechanisms regulate bronchial asthma, it is also likely that cytokines and superoxide radicals generated during hypoxemic episodes could exacerbate reactive airway disease. Patients with Cough, Obstructive sleep apnea, Rhinosinusitis, and Esophageal reflux clustered together can be categorized by the acronym, "CORE", syndrome. The purpose of this manuscript is to review the inflammatory responses that occur in patients with obstructive sleep apnea and relate them to the occurrence of cardiopulmonary disease.

Chronic obstructive pulmonary disease (COPD) and emphysema together are one of the leading causes of death in the United States and worldwide; meanwhile, breast cancer has the highest incidence and second-highest mortality burden of all cancers in women. Imaging markers relevant to each of these conditions are readily identifiable on chest computed tomography (CT): (1) visually-appreciable variants in airway tree structure exist which are associated with increased odds for development of COPD; (2) CT emphysema subtypes (CTES), based on lung texture and spatial features, have been identified by unsupervised clustering and correlate with functional measures and clinical outcomes; (3) dysanapsis, or the ratio of airway caliber to lung volume, is the strongest known predictor of COPD risk, and (4) breast density (i.e., the extent of fibroglandular tissue within the breast) is strongly associated with breast cancer risk. Machine- and deep-learning frameworks present an opportunity to address unmet needs in each of these directions, leveraging the data from large CT cohorts. Application of unsupervised learning approaches serves to discover new, image-based phenotypes. While topologic and geometric variation in the structure of the CT-resolved airway tree are well-described, tree- structural subtypes are not fully characterized. Similarly, while the clinical correlates of CTES have been described in large cohort studies, the association of CTES with structural and functional measures of the lung parenchyma are only partially described, and the time-dependent evolution of emphysematous lung texture has not been studied. Supervised approaches are required to automate CT image assessment, or to estimate CT- based measures from incomplete input data. While dysanapsis can be directly quantified on full- lung CT, the lungs are often only partially imaged in large CT datasets; total lung volume must then be regressed from the observed partial image. Breast density grades, meanwhile, are generally visually assessed, which is laborious to perform at scale. Moreover, current automated methods rely on segmentation followed by intensity thresholding, excluding higher-order features which may contribute to the radiologist assessment. In this thesis, we present a series of machine-learning methods which address each of these gaps in the field, using CT scans from the Multi-Ethnic Study of Atherosclerosis (MESA), the SubPopulations and InteRmediate Outcome Measures in COPD (SPIROMICS) Study, and an institutional chest CT dataset acquired at Columbia University Irving Medical Center. First, we design a novel graph-based clustering framework for identifying tree-structure subtypes in Billera-Holmes-Vogtmann (BHV) tree-space, using the airway trees segmented from the full-lung CT scans of MESA Lung Exam 5. We characterize the behavior of our clustering algorithm on a synthetic dataset, describe the geometric and topological variation across tree-structure clusters, and demonstrate the algorithm’s robustness to perturbation of the input dataset and graph tuning parameter. Second, in MESA Lung Exam 5 CT scans, we quantify the loss of small-diameter airway and pulmonary vessel branches within CTES-labeled lung tissue, demonstrating that depletion of these structures is concentrated within CTES regions, and that the magnitude of this effect is CTES-specific. In a sample of 278 SPIROMICS Visit 1 participants, we find that CTES demonstrate distinct patterns of gas trapping and functional small airways disease (fSAD) on expiratory CT imaging. In the CT scans of SPIROMICS participants imaged at Visit 1 and Visit 5, we update the CTES clustering pipeline to identify longitudinal emphysema patterns (LEPs), which refine CTES by defining subphenotypes informative of time-dependent texture change. Third, we develop a multi-view convolutional neural network (CNN) model to estimate total lung volume (TLV) from cardiac CT scans and lung masks in MESA Lung Exam 5. We demonstrate that our model outperforms regression on imaged lung volume, and is robust to same- day repeated imaging and longitudinal follow-up within MESA. Our model is directly applicable to multiple large-scale cohorts containing cardiac CT and totaling over ten thousand participants. Finally, we design a 3-D CNN model for end-to-end automated breast density assessment on chest CT, trained and evaluated on an institutional chest CT dataset of patients imaged at Columbia University Irving Medical Center. We incorporate ordinal regression frameworks for density grade prediction which outperform binary or multi-class classification objectives, and we demonstrate that model performance on identifying high breast density is comparable to the inter-rater reliability of expert radiologists on this task.

Lau Yin Kei. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (leaves 58-79). / Abstracts in English and Chinese. / Acknowledgement --- p.I / Abstract --- p.IV / Abstract in Chinese --- p.VI / Abbreviations --- p.VIII / Introduction --- p.1 / Chapter 1.1 --- Prevalence of COPD and asthma in Hong Kong --- p.1 / Chapter 1.2 --- Players in pathogenesis of COPD --- p.2 / Chapter 1.3 --- Players in pathogenesis of asthma --- p.4 / Chapter 1.4 --- The use of exhaled breath condensate in previous studies --- p.6 / Chapter 1. 5 --- Brief overview of chemokines --- p.8 / Chapter 1.6 --- Objective of this study --- p.12 / Materials and methods --- p.14 / Chapter 2.1 --- Study population --- p.14 / Chapter 2.1.1 --- Patients with COPD and control subjects --- p.14 / Chapter 2.1.2 --- Patients with asthma and control subjects --- p.15 / Chapter 2.2 --- Lung function --- p.15 / Chapter 2.3 --- Dyspnoea score measurement of patients with COPD --- p.16 / Chapter 2.4 --- Classification of patients and asthma severity --- p.16 / Chapter 2.5 --- Skin prick test and blood tests --- p.16 / Chapter 2.6 --- Collection of exhaled breath condensate --- p.17 / Chapter 2.7 --- Measurement of constituent in EBC --- p.17 / Chapter 2.7.1 --- "Measurement of 8-isoprostane, MCP-1 and GROα in patients with COPD and the corresponding control subjects" --- p.17 / Chapter 2.7.2 --- Measurement of eotaxin and MDC of patients with asthma and the corresponding control subjects --- p.18 / Chapter 2.8 --- Reproducibility of exhaled breath constituent --- p.18 / Chapter 2.8.1 --- "Assessment of reproducibility of the exhaled MCP-1, GROα and8- isoprostane measurements" --- p.19 / Chapter 2.8.2 --- Assessment of reproducibility of the exhaled eotaxin and MDC measurement --- p.19 / Chapter 2.9 --- Statistical analysis --- p.19 / Results --- p.21 / Chapter 3.1 --- Patients with COPD and corresponding control subjects --- p.21 / Chapter 3.2 --- Patients with asthma and corresponding control subjects --- p.28 / Discussion --- p.36 / Chapter 4.1 --- "Exhaled 8-isoprostane, GRO-α and MCP-1 of patients with COPD and corresponding control subjects" --- p.36 / Chapter 4.2 --- Exhaled eotaxin and MDC from patients with asthma and corresponding control subjects --- p.43 / Chapter 4.3 --- Technical aspects of EBC assessment --- p.49 / Future prospect --- p.54 / Conclusion --- p.56 / References --- p.58 / Tables and Figures / Table 1. Demographics of the COPD and control subjects --- p.22 / Figure 1. The level of 8-isoprostane in the exhaled breath condensate of COPD and control subjects --- p.23 / Figure 2. The level of GROa in the exhaled breath condensate of COPD and control subjects --- p.25 / "Figure 3 Bland and Altman's Plot of the repeatability of 8-isoprostane, GROa and MCP-1 in the exhaled breath condensate of normal controls" --- p.27 / Table2. Clinical and physiological details of the subjects --- p.29 / Figure 4. Level of eotaxin in exhaled breath condensate of asthma and control subjects --- p.30 / Figure 5 Level of MDC in exhaled breath condensate of asthma and control subjects --- p.31 / Table 3. Levels of eotaxin and MDC in exhaled breath condensate of asthma subjects on different dose of inhaled corticosteroids --- p.33 / Figure 6. Relationship between exhaled breath condensate level of MDC and total serum IgE level --- p.35

Introdução: A Apneia Obstrutiva do Sono (AOS) é uma doença crônica e evolutiva que tem uma alta prevalência e pode acarretar graves repercussões hemodinâmicas, neurológicas e comportamentais. A pressão positiva contínua na via aérea (CPAP) é altamente eficaz no tratamento da AOS, porém o processo de expansão da faringe por este dispositivo não é totalmente entendido. A faringometria acústica (FA) é um método de mensuração das dimensões da cavidade oral e da faringe, reprodutível e fácil de efetuar, podendo avaliar eficientemente os efeitos do CPAP na faringe e trazer informações sobre sua complacência e sítios de obstrução. Objetivo: avaliar as mudanças induzidas pelo CPAP nas dimensões da faringe e no posicionamento do palato mole em pacientes com AOS e verificar se a deformabilidade da via aérea superior pelo CPAP é maior em apneicos graves do que em roncadores simples. Desenho do estudo: estudo prospectivo. Métodos: 48 pacientes foram submetidos a FA durante o uso do CPAP. 29 pacientes com índice de apneia e hipopneia (IAH) >30 e indicação de uso do CPAP foram inclusos no grupo AOS, e 19 pacientes com IAH <=5 foram inclusos no grupo controle. Os critérios de inclusão foram: idade entre 18 e 65 anos, ambos os sexos, polissonografia (PSG) previamente realizada, e PSG para titulação do CPAP no grupo AOS. Os critérios de exclusão foram: obstrução nasal crônica pré existente, uso de medicamentos psiquiátricos, neurológicos ou miorrelaxantes, insuficiência cardíaca congestiva, índice de massa corpórea >= 35 e cirurgia palatal prévia para AOS. Os gráficos resultantes dos exames de FA foram analisados por 2 examinadores cegos que marcaram os pontos para obtenção da distância da transição orofaríngea da glote. Foram calculados também o comprimento e o volume da faringe pelo programa do aparelho. Foi então feita a análise estatística para comparar as medidas em diferentes pressões intragrupo e intergrupo. Resultados: As medidas dos dois examinadores mostraram correlação. O CPAP não ocasionou nenhum aumento significativo na via aérea faríngea nem mudou o posicionamento do palato em ambos os grupos. No estado basal, os pacientes com AOS têm uma faringe mais longa do que os roncadores simples. Após a aplicação do CPAP, não houve diferença no comprimento e no volume da faringe entre os grupos. Conclusões: Não houve diferenças significantes na posição da transição orofaríngea e da glote entre roncadores e apneicos com a aplicação de CPAP. Não houve expansão significante na via aérea faríngea com a aplicação de CPAP nos roncadores e apneicos. Anatomicamente, os apneicos apresentaram via aérea superior mais longa que os roncadores simples / Rationale: Obstructive Sleep Apnea (OSA) is an evolutive disease, with a high prevalence, that can cause serious hemodynamic, neurological and behavioral repercussions. Continuous positive airway pressure (CPAP) is highly effective in OSA treatment, however the pharynx expansion by this advice is not fully understood. Acoustic pharyngometry (AP) is a measurement method of oral cavity and pharynx dimensions, and can efficiently evaluate CPAP effects on pharynx, bringing informations about its compliance and sites of obstruction. Objectives/Hypothesis: To verify if the CPAP-induced deformability on the pharynx and soft palate is greater in obstructive sleep apnea (OSA) patients than in simple snorers. Study Design: Prospective study. Methods: 29 patients with severe OSA and 19 simple snorers underwent acoustic pharyngometry measurements while awake in supine position. Measurements were first made without CPAP, and then with a nasal CPAP starting with 4cmH2O and up to 10cmH2O. The oropharyngeal transition and the position of the glottis were marked in the generated curves by two blinded examiners. The marked values were averaged to calculate the oropharyngeal transition and the pharyngeal length and volume under zero, 4 and 10cmH2O of CPAP for each group. Results: CPAP did not produce any significant enlargement in the pharyngeal airway nor changed the soft palate positioning in both groups. At baseline, OSA patients have a longer pharynx than simple snorers. After the application of CPAP, there was no difference in the length and volume of the pharynx between groups. Conclusions: There were no significant differences in the position of oropharyngeal junction and glottis between snorers and apneics with CPAP appliance. There was no significant expansion in pharyngeal airway with CPAP appliance in snorers and apneics. Anatomically, apneics presented a longer superior airway than simple snorers

Introdução: A Apneia Obstrutiva do Sono (AOS) é uma doença crônica e evolutiva que tem uma alta prevalência e pode acarretar graves repercussões hemodinâmicas, neurológicas e comportamentais. A pressão positiva contínua na via aérea (CPAP) é altamente eficaz no tratamento da AOS, porém o processo de expansão da faringe por este dispositivo não é totalmente entendido. A faringometria acústica (FA) é um método de mensuração das dimensões da cavidade oral e da faringe, reprodutível e fácil de efetuar, podendo avaliar eficientemente os efeitos do CPAP na faringe e trazer informações sobre sua complacência e sítios de obstrução. Objetivo: avaliar as mudanças induzidas pelo CPAP nas dimensões da faringe e no posicionamento do palato mole em pacientes com AOS e verificar se a deformabilidade da via aérea superior pelo CPAP é maior em apneicos graves do que em roncadores simples. Desenho do estudo: estudo prospectivo. Métodos: 48 pacientes foram submetidos a FA durante o uso do CPAP. 29 pacientes com índice de apneia e hipopneia (IAH) >30 e indicação de uso do CPAP foram inclusos no grupo AOS, e 19 pacientes com IAH <=5 foram inclusos no grupo controle. Os critérios de inclusão foram: idade entre 18 e 65 anos, ambos os sexos, polissonografia (PSG) previamente realizada, e PSG para titulação do CPAP no grupo AOS. Os critérios de exclusão foram: obstrução nasal crônica pré existente, uso de medicamentos psiquiátricos, neurológicos ou miorrelaxantes, insuficiência cardíaca congestiva, índice de massa corpórea >= 35 e cirurgia palatal prévia para AOS. Os gráficos resultantes dos exames de FA foram analisados por 2 examinadores cegos que marcaram os pontos para obtenção da distância da transição orofaríngea da glote. Foram calculados também o comprimento e o volume da faringe pelo programa do aparelho. Foi então feita a análise estatística para comparar as medidas em diferentes pressões intragrupo e intergrupo. Resultados: As medidas dos dois examinadores mostraram correlação. O CPAP não ocasionou nenhum aumento significativo na via aérea faríngea nem mudou o posicionamento do palato em ambos os grupos. No estado basal, os pacientes com AOS têm uma faringe mais longa do que os roncadores simples. Após a aplicação do CPAP, não houve diferença no comprimento e no volume da faringe entre os grupos. Conclusões: Não houve diferenças significantes na posição da transição orofaríngea e da glote entre roncadores e apneicos com a aplicação de CPAP. Não houve expansão significante na via aérea faríngea com a aplicação de CPAP nos roncadores e apneicos. Anatomicamente, os apneicos apresentaram via aérea superior mais longa que os roncadores simples / Rationale: Obstructive Sleep Apnea (OSA) is an evolutive disease, with a high prevalence, that can cause serious hemodynamic, neurological and behavioral repercussions. Continuous positive airway pressure (CPAP) is highly effective in OSA treatment, however the pharynx expansion by this advice is not fully understood. Acoustic pharyngometry (AP) is a measurement method of oral cavity and pharynx dimensions, and can efficiently evaluate CPAP effects on pharynx, bringing informations about its compliance and sites of obstruction. Objectives/Hypothesis: To verify if the CPAP-induced deformability on the pharynx and soft palate is greater in obstructive sleep apnea (OSA) patients than in simple snorers. Study Design: Prospective study. Methods: 29 patients with severe OSA and 19 simple snorers underwent acoustic pharyngometry measurements while awake in supine position. Measurements were first made without CPAP, and then with a nasal CPAP starting with 4cmH2O and up to 10cmH2O. The oropharyngeal transition and the position of the glottis were marked in the generated curves by two blinded examiners. The marked values were averaged to calculate the oropharyngeal transition and the pharyngeal length and volume under zero, 4 and 10cmH2O of CPAP for each group. Results: CPAP did not produce any significant enlargement in the pharyngeal airway nor changed the soft palate positioning in both groups. At baseline, OSA patients have a longer pharynx than simple snorers. After the application of CPAP, there was no difference in the length and volume of the pharynx between groups. Conclusions: There were no significant differences in the position of oropharyngeal junction and glottis between snorers and apneics with CPAP appliance. There was no significant expansion in pharyngeal airway with CPAP appliance in snorers and apneics. Anatomically, apneics presented a longer superior airway than simple snorers